Genomics: Clinical Implementation

This channel includes news headlines and educational resources regarding the clinical implementation of genomics assays, including development, validation, quality control, standardization, and the practical and commercial considerations for labs adopting these tests.

Adventist Health, CancerIQ Collaboration Identifying More Patients for Guidelines-Supported Genetic Testing

Premium

The health system said that the program is encouraging patient compliance and increasing revenues and savings.

Epic EMR Users Begin Integrating Genomics Data for Clinical Decision Support

Premium

With EMR upgrades, Penn and Rush now have structured genomic data informing clinical decision support in their precision oncology programs, but much work remains.

Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing

The groups have written draft recommendations and are now asking for public comment from pathologists and other stakeholders.

Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing

Premium

Paired tumor/germline analysis is not routinely done in cancer care, but some labs are starting to report incidental germline findings alongside patient's tumor profiles.

CMS to Cover FDA-Approved, -Cleared NGS Germline Tests for Breast, Ovarian Cancer Patients

The final national coverage decision stipulates that NGS germline tests for assessing hereditary breast and ovarian cancer risk must have FDA's blessing.

Jan 13, 2020

Guardant Health to Develop Liquid Biopsy CDx for Amgen KRAS G12C Inhibitor

Jan 13, 2020

Adaptive Biotechnologies, Genentech Partner on MRD Testing in Venetoclax Clinical Trial

Jan 09, 2020

Natera Launches Study for Colorectal Cancer Cell-Free DNA Blood Test

Dec 18, 2019

Ambry Genetics, Mayo Clinic Develop Mutation Prevalence Tool to Guide Docs on Appropriate Testing

Premium

Dec 13, 2019

New Data Emerges for Liquid Biopsy in Breast Cancer Residual Disease Detection

Premium

Dec 12, 2019

ACMG Suggests Docs Evaluate All Breast Cancer Patients for Genetic Risk Test Suitability

Dec 09, 2019

ASH Study: Germline Testing Identifies Cancer Risk Mutations, VUS in Older AML Patients

Dec 05, 2019

Polygenic Modifiers of Pathogenic Genes May Refine Disease Risk Prediction

Premium

Dec 04, 2019

NCCN Updates Genetic Testing Guidelines for Assessing Breast, Ovarian, Pancreatic Cancer Risk

Nov 27, 2019

MSK Study With Expanded Liquid Biopsy Panel Supports Value of Tumor-Normal Sequencing

Premium

Nov 22, 2019

Racial Group Comparison Suggests More Research Needed on Prostate Cancer Recurrence Tests

Premium

Nov 12, 2019

AMP Attendees Reflect on Uptake of Tumor Mutational Burden Amid Validation, Utility Questions

Premium

Nov 07, 2019

NSGC Panel Divided on Whether Newly Diagnosed Breast Cancer Patients Should Undergo Panel Testing

Premium

Nov 05, 2019

CIViC Developers Enhancing Variant Database for Greater Use in Precision Oncology

Premium

Oct 29, 2019

CMS Proposes New National Coverage Policy for NGS Germline Testing

Oct 28, 2019

Genomic Test Makers Pilot New Approaches to Overcome Roadblocks in CUP Patient Treatment

Premium

Oct 23, 2019

Metastatic Tumor Profiles Lead to Potential Treatment Targets

Oct 18, 2019

Colon Cancer Recurrence Clues Identified in Post-Treatment ctDNA Detection

Sep 30, 2019

Netherlands Drug Repurposing, Tumor Profiling Trial Results Reported at ESMO

Sep 10, 2019

European Labs Continue to Validate, Implement TMB, Facing Down Cutoff Discordance Concerns

Premium

Menu

Genomics: Clinical Implementation

Adventist Health, CancerIQ Collaboration Identifying More Patients for Guidelines-Supported Genetic Testing

Epic EMR Users Begin Integrating Genomics Data for Clinical Decision Support

Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing

Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing

CMS to Cover FDA-Approved, -Cleared NGS Germline Tests for Breast, Ovarian Cancer Patients

Guardant Health to Develop Liquid Biopsy CDx for Amgen KRAS G12C Inhibitor

Adaptive Biotechnologies, Genentech Partner on MRD Testing in Venetoclax Clinical Trial

Natera Launches Study for Colorectal Cancer Cell-Free DNA Blood Test

Ambry Genetics, Mayo Clinic Develop Mutation Prevalence Tool to Guide Docs on Appropriate Testing

New Data Emerges for Liquid Biopsy in Breast Cancer Residual Disease Detection

ACMG Suggests Docs Evaluate All Breast Cancer Patients for Genetic Risk Test Suitability

ASH Study: Germline Testing Identifies Cancer Risk Mutations, VUS in Older AML Patients

Polygenic Modifiers of Pathogenic Genes May Refine Disease Risk Prediction

NCCN Updates Genetic Testing Guidelines for Assessing Breast, Ovarian, Pancreatic Cancer Risk

MSK Study With Expanded Liquid Biopsy Panel Supports Value of Tumor-Normal Sequencing

Racial Group Comparison Suggests More Research Needed on Prostate Cancer Recurrence Tests

AMP Attendees Reflect on Uptake of Tumor Mutational Burden Amid Validation, Utility Questions

NSGC Panel Divided on Whether Newly Diagnosed Breast Cancer Patients Should Undergo Panel Testing

CIViC Developers Enhancing Variant Database for Greater Use in Precision Oncology

CMS Proposes New National Coverage Policy for NGS Germline Testing

Genomic Test Makers Pilot New Approaches to Overcome Roadblocks in CUP Patient Treatment

Metastatic Tumor Profiles Lead to Potential Treatment Targets

Colon Cancer Recurrence Clues Identified in Post-Treatment ctDNA Detection

Netherlands Drug Repurposing, Tumor Profiling Trial Results Reported at ESMO

European Labs Continue to Validate, Implement TMB, Facing Down Cutoff Discordance Concerns

Sponsorships